NEW
Lucentis樂明睛

Lucentis Indications/Uses

ranibizumab

Manufacturer:

Novartis

Distributor:

Zuellig
/
Agencia Lei Va Hong
Full Prescribing Info
Indications/Uses
Lucentis is indicated in adults for: The treatment of neovascular (wet) age-related macular degeneration (AMD); The treatment of visual impairment due to diabetic macular oedema (DME); The treatment of proliferative diabetic retinopathy (PDR); The treatment of visual impairment due to choroidal neovascularisation (CNV); The treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO).
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in